BioIntel is now The Catalyst Brief.
The Catalyst Brief
Coverage

Medical Technology

Digital health, diagnostics and medical devices, and the signals that matter for adoption, reimbursement and outcomes.

Page 4 of 9

Archive

Have Healthcare Data Lakes Become ‘Data Swamps’? Navigating Complexity and Unlocking ValueJun 27, 2026

Have Healthcare Data Lakes Become ‘Data Swamps’? Navigating Complexity and Unlocking Value

Healthcare data lakes were once seen as the future for storing vast volumes of information, promising analytic breakthroughs for research and patient care. Increasingly, stakeholders warn these lakes are turning into 'swamps,' hampered by unusable data, challenging navigation, and uncertainty on what value can really be extracted. We take an independent look at why these problems have emerged, how they impact care delivery and health system operations, and strategies being developed to turn swamps back to lakes.

The Catalyst Brief
FDA Grants Breakthrough Status to Generative AI for Radiology: What It Means for Medical ImagingJun 25, 2026

FDA Grants Breakthrough Status to Generative AI for Radiology: What It Means for Medical Imaging

In a notable move for the medical imaging sector, the FDA recently granted breakthrough designation to two devices leveraging generative AI. These devices are designed to interpret chest X-rays and automate report generation, highlighting the growing importance and clinical acceptance of artificial intelligence in radiology workflows. This development has the potential to redefine both efficiency and accuracy in imaging departments across the United States.

The Catalyst Brief
Xella Health Debuts with $499 Membership Model, Targeting Gaps in Women’s HealthcareJun 25, 2026

Xella Health Debuts with $499 Membership Model, Targeting Gaps in Women’s Healthcare

With a model evocative of high-end concierge medicine, Xella Health positions itself as a connected healthcare solution dedicated to women’s unique health needs. Launching with a $499 yearly fee, the platform aims to democratize previously exclusive offerings by providing continuity, context, and holistic support for female patients.

The Catalyst Brief
OpenEvidence to Integrate FDA-Cleared AI for Heart Disease Detection: A Closer Look at Tech’s Growing Role in CardiologyJun 23, 2026

OpenEvidence to Integrate FDA-Cleared AI for Heart Disease Detection: A Closer Look at Tech’s Growing Role in Cardiology

As OpenEvidence prepares to integrate a newly FDA-cleared AI tool into its platform for heart disease detection, the intersection of machine learning and cardiovascular healthcare takes a significant leap forward. This development draws attention not only for its clinical applications, but also for the broader context of how regulated artificial intelligence is reshaping treatment paradigms and approaches to chronic disease worldwide.

The Catalyst Brief
Whole-Body MRI Companies Face Scrutiny Over Inflated Medical ClaimsJun 18, 2026

Whole-Body MRI Companies Face Scrutiny Over Inflated Medical Claims

A major debate has emerged around the value and safety of elective whole-body MRI services promoted to healthy adults. Two leading radiologists, writing in a JAMA editorial, have taken aim at the marketing claims of several companies, suggesting that such scans could trigger more medical harm than benefit. The industry’s three largest firms have pushed back on those criticisms, defending the utility of their offerings.

The Catalyst Brief
AI Won’t Fix Physician Burnout — Giving Them More Autonomy WillJun 18, 2026

AI Won’t Fix Physician Burnout — Giving Them More Autonomy Will

AI tools are transforming documentation burdens in healthcare, but a crucial issue persists: physicians continue to struggle with burnout not because of records, but because of the profound loss of autonomy in their daily work. Understanding the underlying causes and evaluating the right solutions is increasingly central to the medical workforce crisis.

The Catalyst Brief
What AI Is Getting Right—and Wrong—in Healthcare Revenue Cycle ManagementJun 18, 2026

What AI Is Getting Right—and Wrong—in Healthcare Revenue Cycle Management

AI is increasingly being leveraged to improve various processes within healthcare’s revenue cycle. Although AI technologies are demonstrating progress, certain gray areas and challenges persist, leaving questions about the future trajectory of automation in healthcare billing and collections.

The Catalyst Brief
What’s Flowing Beneath the World Cup: How Verily’s Wastewater Monitoring Could Catch the Next OutbreakJun 16, 2026

What’s Flowing Beneath the World Cup: How Verily’s Wastewater Monitoring Could Catch the Next Outbreak

As global attention focuses on the World Cup, Verily is piloting a novel approach to public health surveillance: testing wastewater in host cities for traces of key pathogens. This initiative, targeting viruses and bacteria like RSV, measles, and norovirus, could enable public health officials to identify outbreaks days before they manifest in clinics and hospitals.

The Catalyst Brief
Restoring the Patient-Clinician Relationship to the Center of CareJun 11, 2026

Restoring the Patient-Clinician Relationship to the Center of Care

While digital tools proliferate across healthcare, emerging thought leadership argues that true progress in patient experience hinges on giving clinicians the capacity to be fully present at the bedside. This shift calls for systemic changes that emphasize quality of caregiving over mere digital engagement.

The Catalyst Brief
DiMe Launches New Initiative Targeting Virtual-First Care Contract ChallengesJun 11, 2026

DiMe Launches New Initiative Targeting Virtual-First Care Contract Challenges

The Digital Medicine Society's new initiative aims to eliminate common pitfalls in contracting for virtual-first care, as healthcare organizations navigate the complex shift toward digital medicine. The project brings together technology innovators, payers, and care providers to facilitate smoother digital integration and better patient outcomes.

The Catalyst Brief

Other beats

AI in Drug Discovery

Machine learning, predictive models and computational biology: how AI is changing discovery workflows and probability of success.

Biopharmaceutical Industry

Drug development, clinical trials and industry dynamics. What changes timelines, risk and competitive positioning.

Biotech Innovation

Gene therapy, CRISPR, synthetic biology and emerging platforms. Separating what is real from what is hype, and what actually translates.

Healthcare Investment

Where capital is flowing and why the tape moves, across funding rounds, M&A, IPOs and market analysis.

Regulatory & Policy

FDA actions, approvals, policy shifts and compliance: how the rules change timelines and probability.